When it comes to adopting healthcare AI, large, well-off hospitals are likely to frequently homer while smaller, struggling institutions go down looking. (Baseball analogy in honor of tonight’s Midsummer Classic.) 

Morphic's new treatment for inflammatory bowel disease is in Phase II clinical trials and shows promise in improving patient outcomes. Eli Lilly will purchase the company for $57 per share in cash.

According to a report, from 2019 and 2021, Medicare Advantage plans put taxpayers on the hook for dubious care services.

The average payment rate to physicians is suggested to be reduced by 2.93% in 2025 under the proposed fee schedule change, the agency noted. 

Buzzworthy developments of the past few days.

Using the technology and making it work for purpose are two different things. And the U.S. leads all countries in terms of full implementation, at 24% (vs. 19% for China).

Several state attorneys general have issued notices to residents regarding the Change Healthcare breach, asking them to sign up for credit monitoring and identity theft protection.

Jim Melton, DO, a vascular surgeon in Oklahoma City, explains his efforts to reach patients in rural Oklahoma and Native American tribes with a mobile cardiovascular clinic program.